Nicholas Hud was born and raised in Los Angeles, California. He received his B.S. degree in physics from Loyola Marymount University. His Ph.D. was conferred by the University of California, Davis for physical investigations of DNA condensation by protamine. From 1992-1995 he was a postdoctoral fellow in the biology and biotechnology research program at Lawrence Livermore National Laboratory with Rod Balhorn. From 1995-1998 he was an NIH postdoctoral fellow in the Molecular Biology Institute at UCLA where he worked with Juli Feigon and Frank A. L. Anet on the application of NMR spectroscopy to the study of DNA-cation interactions. Hud joined the faculty at Georgia Tech as an assistant professor in 1999 and was promoted to full professor in 2008. He has been visiting professor of chemistry at the National NMR Center in Slovenia, and at Imperial College London. Hud currently serves as PI of the NSF Center for Chemical Evolution, as chair of the biochemistry division of the School of Chemistry and Biochemistry, as co-director of the Georgia Tech-Emory University Center for Fundamental and Applied Molecular Evolution (FAME), and as associate director of the Petit Institute for Bioengineering and Bioscience.

Robert E. Guldberg is the DeArmond Executive Director of the Phil and Penny Knight Campus for Accelerating Scientific Impact and Vice President of the University of Oregon. Guldberg’s research is focused on musculoskeletal mechanobiology, regenerative medicine, and orthopaedic medical devices. Over his 25+ year academic career, Dr. Guldberg has produced over 280 peer-reviewed publications, served as an advisor and board member for numerous biotechnology companies, and co-founded six start-ups. He was previously executive director of the Parker H. Petit Institute for Bioengineering and Bioscience at Georgia Tech from 2009-2018. In 2018, he was selected from a national search to lead the Knight Campus as its inaugural permanent Executive Director, where he has led the creation of its strategic plan, hired faculty into the campus’ first building opened in 2020, and launched the University of Oregon’s first ever engineering degree program. In 2021, he led the launch of Phase 2 of the Knight Campus development with the announcement of a second $500 million gift from Phil and Penny Knight. At the national level, Dr. Guldberg is past Chair of the Americas Chapter of the Tissue Engineering and Regenerative Medicine International Society (TERMIS-AM). He currently serves on the Executive Leadership Council of the Wu Tsai Human Performance Alliance, a $220 million global initiative to promote wellness and peak performance through scientific discovery and innovation. Dr. Guldberg is an elected fellow of TERMIS, the American Society of Mechanical Engineers (ASME), the American Institute for Medical and Biological Engineering (AIMBE), the Orthopaedic Research Society (ORS), and the National Academy of Inventors (NAI).

Gaucher was guided in biochemistry by Peter Tipton and Bayesian Theory by George Smith. Gaucher subsequently earned his Ph.D. from the University of Florida under the tutelage of Steve Benner and Michael Miyamoto.[1] Gaucher received the Walter M. Fitch Award from the Society for Molecular Biology and Evolution for his graduate work.[2] He then did postdoctoral work with NASA's Astrobiology Institute in conjunction with a National Research Council Fellowship. After the two-year fellowship, Gaucher served as President of the Foundation for Applied Molecular Evolution.

Gaucher was hired as an Associate Professor by the Georgia Institute of Technology in 2008 [1][3][4] The Gaucher group conducts basic and applied research at the interface of molecular evolution and synthetic biology. As of February 2016, his h-index, as calculated by Google Scholar, is 25.[5]

Gaucher is also the founder and president of the early-stage biotechnology company General Genomics. His company exploits novel platforms to engineer proteins for the biomedical and industrial sectors.

Faces of Research - Profile Article

Michelle’s research is themed around designing and characterizing the surface chemical properties of synthetic and natural polymer systems. They will be used to develop multifunctional biomaterial substrates for regenerative medicine, cancer treatment, and personal care products. The goals of the Gaines Lab are achieved by marrying Polymer Synthesis, Materials Science, Cell Biology & Spectroscopy.

Stefan France is an Associate Professor in the School of Chemistry and Biochemistry. Professor France earned his B.S. in Chemistry (2000) from Duke University and a M.A. (2003) and Ph.D. (2005) in Organic Chemistry from Johns Hopkins University. His research group focuses on experimental methodology development, natural product synthesis, and medicinal chemistry. Owing to Prof. France's avid interest in undergraduate research, his research group has mentored and trained more than 60 undergraduates (both Georgia Tech and non-Georgia Tech students). Professor France has been the recipient of several awards for his research, mentorship, and teaching including: the 2018 Georgia Tech-Georgia Power Professor of Excellence; the 2015 Georgia Tech Senior Faculty Outstanding Undergraduate Mentor Award; the 2014 Georgia Tech Faculty Award for Academic Outreach; the 2014 Georgia Tech Hesberg Teaching Award; the 2013 Georgia Tech Sigma Xi Young Faculty Award; the 2012 National Organization for the Professional Advancement for Black Chemists and Chemical Engineers (NOBCChE) Lloyd N. Ferguson Young Scientist Award; and the 2011 National Science Foundation (NSF) CAREER Award. He heads the Chemistry FAST Program, a NSF Research Experiences for Undergraduates (REU) Site, and also serves as Chair of the NSF Chemistry REU Leadership Group.

Craig Forest is a Professor and Woodruff Faculty Fellow in the George W. Woodruff School of Mechanical Engineering at Georgia Tech where he also holds program faculty positions in Bioengineering and Biomedical Engineering. He conducts research on miniaturized, high-throughput robotic instrumentation to advance neuroscience and genetic science, working at the intersection of bioMEMS, precision machine design, optics, and microfabrication. Prior to Georgia Tech, he was a research fellow in Genetics at Harvard Medical School. He obtained a Ph.D. in Mechanical Engineering from MIT in June 2007, M.S. in Mechanical Engineering from MIT in 2003, and B.S. in Mechanical Engineering from Georgia Tech in 2001. He is cofounder/organizer of one of the largest undergraduate invention competitions in the US—The InVenture Prize, and founder/organizer of one of the largest student-run makerspaces in the US—The Invention Studio. He was a recently a Fellow in residence at the Allen Insitutte for Brain Science in Seattle WA; he was awarded the Georgia Tech Institute for BioEngineering and BioSciences Junior Faculty Award (2010) and was named Engineer of the Year in Education for the state of Georgia (2013). He is one of the inaugural recipients of the NIH BRAIN Initiative Grants, a national effort to invent the next generation of neuroscience and neuroengineering tools. In 2007, he was a finalist on the ABC reality TV show "American Inventor.”

Faces of Research - Profile Article

Fedorov's background is in thermal/fluid sciences, chemical reaction engineering as well as in applied mathematics. His laboratory works at the intersection between mechanical and chemical engineering and solid state physics and analytical chemistry with the focus on portable/ distributed power generation with synergetic CO₂ capture; thermal management of high power dissipation devices and electronics cooling; special surfaces and nanostructured interfaces for catalysis, heat and moisture management; and development of novel bioanalytical instrumentation and chemical sensors. Fedorov joined Georgia Tech in 2000 as an assistant professor after finishing his postdoctoral work at Purdue University.

Dr. Stanislav Emelianov is a Joseph M. Pettit Endowed Chair, Georgia Research Alliance Eminent Scholar, and Professor of Electrical & Computer Engineering and Biomedical Engineering at the Georgia Institute of Technology. He is also appointed at the Emory University School of Medicine, where he is affiliated with Winship Cancer Institute, Department of Radiology, and other clinical units. Furthermore, Dr. Emelianov is Director of the Ultrasound Imaging and Therapeutics Research Laboratory at the Georgia Institute of Technology focused on the translation of diagnostic imaging & therapeutic instrumentation, and nanobiotechnology for clinical applications. 

Throughout his career, Dr. Emelianov has been devoted to the development of advanced imaging methods capable of detecting and diagnosing cancer and other pathologies, assisting treatment planning, and enhancing image-guided therapy and monitoring of the treatment outcome. He is specifically interested in intelligent biomedical imaging and sensing ranging from molecular imaging to small animal imaging to clinical applications. Furthermore, Dr. Emelianov develops approaches for image-guided molecular therapy and therapeutic applications of ultrasound and electromagnetic energy. Finally, nanobiotechnology plays a critical role in his research. In the course of his work, Dr. Emelianov has pioneered several ultrasound-based imaging techniques, including shear wave elasticity imaging and molecular photoacoustic imaging. Overall, projects in Dr. Emelianov's laboratory, which focuses on cancer and other diseases, range from molecular imaging to functional imaging and tissue differentiation, from drug delivery and release to image-guided surgery and intervention.